Dalbavancin 500mg Powder for concentrate for solution for infusion (under development)

Product description

Dalbavancin 500mg Powder for concentrate for solution for infusion
Reference Product: Xydalba® / Allergan Pharmaceuticals International Ltd
Description: Dalbavancin is a glycopeptide antibacterial which is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
Dossier Status: On-going
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Four (4) years
Batch Sizes: To be defined
Pack Sizes: To be defined / Originator pack: BT x 1 vial (Single-use 48 ml type I glass vial)
Read more

Specifications

Categories APIs (Active Pharmaceutical Ingredients)Antibiotics; Finished Dosage FormsInjectables; Finished Dosage FormsOut-licensing
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Greece

More products from ANFARM HELLAS S.A.

View all our products (30)

Products from other suppliers